Micromem Technologies Inc. (CSE: MRM | OTCQB: MMTIF) announced on November 9, 2026 that it has fulfilled all financial obligations under its collaboration agreement with the University of Toronto, the Natural Sciences and Engineering Research Council of Canada, and Defence Research and Development Canada. The company stated that completion of its final payment confirms its ongoing rights to access intellectual property developed under the agreement. The milestone is significant for investors tracking Micromem's advancement of proprietary nanowire-based sensing technologies for defence, industrial, and environmental applications.

Key Points

  • Micromem Technologies Inc. (CSE: MRM | OTCQB: MMTIF) is a Toronto-based nanotechnology sensor company
  • The company has completed all financial obligations under its collaboration agreement originally announced March 3, 2025
  • The agreement covers the project "Development of a Nanowire Field Effect Transistor Biochemical Sensor" targeting picomolar-level biomarker detection
  • Investors may be watching progress on the compact gas-sensing wearable/portable prototype and its planned oil industry and municipal water quality testing applications

Final Payment Secures Micromem's Intellectual Property Rights Under Multi-Party Agreement

Micromem confirmed that its final payment under the collaboration agreement — first announced on March 3, 2025 — has been made, fulfilling the company's financial commitment to its partners. The release states that this completion confirms Micromem's rights to access intellectual property developed pursuant to the agreement, including IP still to be developed going forward. The company will continue participating in ongoing collaboration with the University of Toronto, NSERC, and DRDC, maintaining access to research outputs as the project progresses. The financial terms and total payment amount were not disclosed in the announcement.

Nanowire Biochemical Sensor Project Targets Ultra-Low Concentration Disease Biomarker Detection

The core research project under the agreement focuses on developing a liquid-phase nanowire bio-chemical sensor capable of detecting disease-associated biomarkers at ultra-low concentrations using what the company describes as breakthrough picomolar detection capability. The release states that project work is continuing toward this development goal. Micromem describes its broader technology platform as nanowire-based sensing engineered for high sensitivity, with intended applications spanning defence, healthcare, environmental monitoring, industrial safety, and energy sectors. The immediate share price impact was not clear from available public information.

Compact Gas-Sensing Prototype Targets Oil Industry and Military Wearable Applications

Separately, the company noted it is advancing development of a compact gas-sensing wearable and portable prototype in collaboration with the University of Toronto and DRDC, referencing a prior announcement dated October 26, 2026. The release states the prototype is intended as the commercial version of the technology and will initially serve oil industry and municipal water quality testing use cases. The prototype is also described as the base technology for wearable military applications being developed for the Canadian Department of National Defence. No timeline or commercialisation milestones were disclosed in this announcement.